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Background. Granulomatosis with polyangiitis (GPA) is an ANCA associated small vessel vasculitis characterized by necrotizing
granulomatous inflammation involving the upper and the lower respiratory tract and the kidneys. The disease has a broad clinical
spectrum that ranges from limited/localized involvement of a single organ system to a generalized systemic vasculitis that affects
several organs with evidence of end organ damage. Atypical forms of the disease have been recognized with or without respiratory
tract involvement with a long protracted course before manifesting as generalized disease. Case Presentation. We describe a 57year-old woman who presented with recurrent fever and cutaneous ulcers on her legs who was diagnosed to have granulomatosis
with polyangiitis (GPA) after an extensive evaluation which excluded infectious, other vasculitides, connective tissue disease and
malignant etiologies. Conclusion. In the absence of typical manifestations, granulomatosis with polyangiitis (GPA) is indeed a
diagnostic challenge to the physician. Atypical manifestations like unexplained recurrent fever and cutaneous ulcers nevertheless
call for keeping a low threshold for the diagnosis of GPA as the disease can initially present in localized form before heralding into
a generalized disease.

1. Introduction
Granulomatosis with polyangiitis (GPA) is a small vessel vasculitis with an array of systemic manifestations. The hallmark
of this disease is granulomatous inflammation involving the
upper and lower respiratory tract with or without the involvement of kidneys [1]. However, the disease can involve virtually
any organ in the body as generalized disease or as a limited/localized disease. In the localized disease, the inflammation is confined to eyes, ears, nose, and lungs but other organs
may get involved including heart, skin, gastrointestinal tract,
and the peripheral nervous system. Cutaneous vasculitis secondary to GPA can present as papules, nodules, palpable purpura, ulcers resembling pyoderma gangrenosum, or necrotizing lesions leading to gangrene [2]. There is no single lesion
specifically associated with the disease. Cutaneous lesions

are found in 50% of patients [3] but may be the presenting
symptoms in up to 10% of cases. It is therefore of utmost
importance to consider GPA in the differential diagnosis
of small vessel cutaneous vasculitis so that the disease can
be identified early in the clinical course and treated appropriately to prevent morbidity associated with complications
arising from generalized disease [4]. Systemic GPA can cause
life threatening diffuse alveolar hemorrhages as a result of
necrotizing alveolar capillaritis and kidney failure necessitating hemodialysis due to rapidly progressive glomerulonephritis [5].
Granulomatosis with polyangiitis has a strong association with antineutrophil cytoplasmic antibodies (ANCAs)
which characteristically have a cytoplasmic labeling pattern (C-ANCA) in immunofluorescence assays directed
against proteinase-3 and myeloperoxidase [6]. These are IgG
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Table 1: Laboratory data.
Investigations
Hb/Hct
WBC
Platelet count
Blood urea nitrogen
Serum creatinine
Total bilirubin (direct/indirect)
Alanine aminotransferase
Alkaline phosphatase
Figure 1: Initial lesion: erythematous nodule on right shin.
Urinalysis

antibodies directed against primary granules of the neutrophils and the lysosomes of monocytes [7]. ANCA can be
seen in 80–95% of the patients with generalized disease but
in limited presentations ANCA is detectable in only 60%–
80% of the cases and remains negative in 20%. Hence it is
imperative to obtain tissue biopsy for histopathological evaluation as a more definitive means to diagnose this disease [6].

2. Case Presentation
A 57-year-old woman presented to the rheumatology clinic
with recurrent fever and painful ulcers on her legs since
two months. Eight months prior to current presentation, she
developed vertigo and decreased hearing in her left ear which
she felt was “full of air” all the time. She was found to have sensorineural deafness in her left ear. Two weeks later, she developed fever with chills. A chest radiograph revealed infiltrates
in her right lung and an elevated ESR. She was treated with
oral antibiotics which relieved her symptoms. Then she developed gingival hypertrophy and a CT scan of the paranasal
sinuses revealed subcutaneous soft tissue thickening of the
right buccal area suggestive of an inflammatory process. She
was treated with ibuprofen and felt better. Her past medical
history was notable for hypothyroidism for 20 years and she
as well was maintained on 50 mcg of thyroxin daily. She had
undergone hysterectomy for uterine fibroids 15 years ago.
She reported no recent travel history. Of note, she revealed
contact with sick animals. She nursed her paralyzed pet dog
and also had cats. She was treated with antibiotics yet continued to spike fever and came to our center for comprehensive
evaluation. On examination, she appeared weak and ill. The
temperature was 37.5∘ C, the blood pressure 139/69 mm Hg,
the pulse 78 beats per minute, and the respiratory rate 16
breaths per minute, with 99% oxygen saturation at room air.
Erythematous tender nodules were noticed on bilateral lower
extremities (Figure 1).
The remainder of the examination was unremarkable. Her complete blood count revealed normocytic, normochromic anemia with normal white cell and platelet count.
Her biochemistry showed normal kidney and liver function.
No active sediment was present on urinalysis. Her three sets
of blood cultures and one urine culture reported no growth.

Blood cultures (3 sets)
Urine culture
Interferon gamma release assay
(IGRA)
Brucella abortus and melitensis
titres
Hepatitis B surface antigen
(HBsAg)
Anti-HCV antibody
Antinuclear antibody
Anti-dsDNA
ACCP antibody
QRA
c-ANCA
p-ANCA
Angiotensin converting enzyme

Results
10.5/35
8.5 × 109 /L
226 × 109 /L
12 mg/dL
0.8 mg/dL
0.7 mg/dL (0.5/0.2)
13 U/L
107 U/L
pH: 5.5, no glucose/ketones/casts/protein,
WBCs 3-4/high power field
No growth
No growth
Negative
<1 : 80 ×2
Negative
Negative
Negative
Negative
Negative
27.7 (elevated)
Negative (0.8 U/mL)
Negative (1.86 U/mL)
40 U/L (normal <52 U/L)

The test for latent tuberculosis by interferon gamma release
assay (IGRA) was also negative. Serology for Brucella abortus
and melitensis also came negative. Tests for chronic viral hepatitis B and C were also normal. Serological tests for connective tissue disease were negative as was the serum angiotensin
converting enzyme level. Other relevant investigations are
outlined in Table 1. An upper abdominal ultrasound showed
hypoechoic, cystic lesions scattered across both lobes of the
liver (Figure 2). A subsequent CT scan of the abdomen with
contrast showed multiple oval hypoattenuating lesions in
both lobes of the liver (Figure 3).
On liver biopsy there was evidence of cholestasis and
multiple large irregular areas of necrosis, palisaded by epitheloid cells with associated granulomatous inflammation with
a number of plasma cells (Figure 4).
Acid-fast bacilli culture of liver biopsy specimen after six
weeks came out negative. Meanwhile, the patient continued
to spike fever with maximum temperature of 101∘ F. Leg lesions
were becoming worse with central necrosis and purulent
discharge (Figures 5 and 6).
Pus cultures were negative for bacterial, fungal, and
mycobacterial growth. A biopsy of the skin was performed.
Pathological examination of frozen sections revealed surface
ulceration with fibrinoid necrosis and vasculitis involving
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Figure 2: Ultrasound upper abdomen. Multiple hypoechoic tiny
lesions on both lobes, few of them cystic in appearance.

Figure 3: CT abdomen with contrast: multiple hypoattenuating
lesions in the liver.

Figure 4: Liver biopsy. Cholestasis with multiple large areas of
necrosis palisaded by epitheloid cells with associated granulomatous
inflammation.
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Figure 6: Ulceration progressing to central necrosis.

Figure 7: Skin biopsy. Vasculitis involving the superficial and deep
dermis showing fibrinoid necrosis of vessel wall with granuloma
formation, neutrophilic infiltrate, and nuclear debris.

superficial and deep dermal vessels along with granuloma
formation, neutrophilic infiltration, and debris (Figure 7).
Immunohistochemical testing was performed on biopsy
specimen using immune-alkaline phosphatase technique
which came negative for mycobacterial species. Real-time
PCR for mycobacterial species also turned out to be negative.
It was concluded from the skin biopsy that the patient
had cutaneous granulomatous vasculitis. Treatment was
commenced with prednisone 1 mg/kg/day and the patient
was offered induction with cyclophosphamide which she
refused due to associated toxicities. Meanwhile, azathioprine
2 mg/kg/day was added to prednisone. After seven weeks on
prednisone and six weeks of azathioprine her lesions had
healed almost completely (Figure 8). She was maintained on
prednisone 5 mg bid and azathioprine 50 mg bid with healing
lesions. A repeat CT scan of the abdomen revealed normal
architecture of hepatic parenchyma.
Therefore, considering a chronic inflammatory process
characterized by hearing loss, gingival hypertrophy, granulomatous hepatic lesions, and cutaneous ulcers with necrotizing
granulomatous inflammation on skin biopsy, a unifying
diagnosis of granulomatosis with polyangiitis (GPA) was
made.

3. Discussion
Figure 5: Ulceration in the nodule with erythema and discharge.

Granulomatosis with polyangiitis (GPA) is complex multisystemic disease with varying manifestations. The 2012 Chapel
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Table 2: Case reports of localized GPA with cutaneous manifestations.

Author and year of
publication

Diagnosis

Organ involvement

ANCA

Kihiczak et al. [13]
1994

Protracted superficial GPA

Skin, nasal mucosa

N/A

Figarella et al. [14]
2000

Protracted superficial GPA

Upper respiratory tract,
skin, and lung

N/A

Brazzelli et al. [32]
1999

Cutaneous GPA

Acneiform nodular and
popular eruption on
forehead, dense pulmonary
infiltrates

Positive

Kuchel and Lee [21]
2003

Cutaneous GPA

Skin involving ear lobe,
ankles, and feet

Negative

Sinovich and Snow [33]
2003

Protracted superficial GPA

Infra-auricular skin and
nasal mucosa

Positive

Kawakami et al. [34]
2005

GPA with cutaneous
leukocytoclastic vasculitis

Skin, lung, and kidney

Positive

Ben Ghorbel et al. [35]
2007

Cutaneous and mucosal
GPA as initial presentation
in an adult

Tongue and labial ulcers,
digital necrosis, splinter
hemorrhages of fingernails,
and purpura

Positive

Ben Ghorbel et al. [15]
2007

Recurrent digital necrotic
ulcers on fingers, toes, and
scapula as cutaneous GPA
in a child

Nasal mucosa, eyes
(keratitis), and skin

Positive

Superficial ulcerations with
granulomatous vasculitis

Thaiwat and Aunhachoke
[22]
2010

Superficial GPA with
chronic scalp ulcer

Skin

Negative

Solitary nodule on scalp with
alopecia; nodules on left arm and
shin; purpura

Hill Consensus conference defines GPA as necrotizing granulomatous inflammation usually involving the upper and
lower respiratory tract and necrotizing vasculitis affecting
predominantly small to medium vessels [8]. However, it
is known to involve other organs with variable frequency
either as part of the “generalized” disease or as “limited” or
“localized” forms [9]. In this form, the disease does not fulfill
the diagnostic criteria early in the course but years later can
herald in a severe life threatening multiorgan form [10].
The initial symptoms in our patient were vertigo and
decreased hearing in her left ear. Thereafter, she developed
fever and respiratory symptoms followed by gingival hypertrophy. Later on she developed cutaneous lesions and persistent fever. Cutaneous involvement in GPA can occur in isolation [11] or as part of a generalized disease. Longitudinal studies of organ involvement in more than 100 patients with GPA
have reported frequent skin involvement [4, 5, 12]. The localized or limited presentation of this disease can also appear
as cutaneous lesions years before the involvement of other

Clinical course
Protracted course characterized
by granulomatous skin and nasal
ulcers
Skin nodules on leg present for 10
years, before the diagnosis was
established based on cutaneous
histopathology
Necrotic ulcers on forearms,
arms, and buttocks, small vessel
vasculitis of deep dermis
Responded to prednisone and
CYC, granulomatous
inflammation on biopsy
Pyoderma gangrenosum like
lesions with suppurative
granulomatous inflammation.
Responded to prednisone and
azathioprine
Various cutaneous
manifestations. Palisading
neutrophilic granulomatous
dermatitis on histopathology
Diagnosis confirmed on
cutaneous and renal biopsies.
Resolution of cutaneous disease
after 6 weeks of treatment with
prednisone and CYC

systems (Table 2). Kihiczak et al. [13] described a 36-yearold woman who was initially diagnosed as case of sarcoidosis
based on conjunctival and nasal mucosal biopsy. Later on,
atypical GPA with granulomatous ulcers was diagnosed, after
a long protracted course [13]. In another patient, the disease
appeared as recurrent nodular lesions on legs with biopsy
suggesting nonspecific inflammation. However ten years
later, when pulmonary symptoms developed, a repeat skin
biopsy showed granulomatous vasculitis as an underlying
cause for both cutaneous and pulmonary disease [14]. In yet
another report [15], cutaneous finding included papulonodular acneiform eruption followed by development of necrotic
ulcers on forehead, arms, and buttocks. Similar evolution of
lesion was also noted in our patient who initially had nodular
lesions which later evolved into deep necrotizing ulcers.
With the established role of antineutrophil cytoplasmic
autoantibodies or ANCAs in the pathogenesis of disease and
the availability of commercially available assays, clinicians
have better tools to diagnose this complex disease [16]. ANCA
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Figure 8: After treatment with 7 weeks of prednisone and azathioprine.

is highly positive in patients with severe generalized disease
compared to patients with limited disease [17]. However,
commercial ANCA ELISAs have not been standardized and
vary in their sensitivity and specificity [18]. Sensitivity of
ANCA varies according to the assay used and study design,
including differences in disease severity and treatment, with
figures varying from 34% to 92% [18]. The ANCA can be
negative in limited disease as was the case in our patient.
In one study, ANCAs were detectable in only 46% of the
patients who present with limited/localized disease [19]. In
these patients the disease was confined to upper and/or lower
respiratory tract with no clinical signs of vasculitis or as early
systemic disease and no other feature of organ threatening
vasculitis or as limited disease with localized or early systemic
manifestation [19]. Patients with localized disease were also
younger with a female predominance [19]. In some patients
ANCA can never be detected despite persistent disease. Ettl
et al. [20] reported a life threatening form of GPA, in which
ANCA remained negative despite a fulminant disease course.
Then certainly there are instances where cutaneous GPA was
not associated with a positive ANCA [21, 22].
Characteristic findings that aid in establishing the diagnosis include histological evidence of focal necrosis, fibrinoid degeneration, palisading granuloma surrounded by
neutrophils and histiocytes, and granulomatous vasculitis
with lymphohistiocytic infiltrates involving muscular walls
[23]. Nonpalisading foci of granular necrosis or fibrinoid
degeneration precede the development of the typical palisading granuloma [24]. Interestingly, our patient presented with
both cutaneous and hepatic lesions so she underwent both
skin and liver biopsies. With a negative ANCA, the diagnosis
in our patient was established on histopathology. Her skin
biopsy showed superficial ulceration, vasculitis of superficial
and deep dermis comprising of fibrinoid necrosis of vessel
wall with granuloma formation and neutrophilic infiltrate
and nuclear debris consistent with cutaneous granulomatosis
with polyangiitis.
Sections examined from the liver biopsy revealed
cholestasis and multiple areas of necrosis palisaded by
epitheloid cells and chronic inflammation consistent with
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granulomatous hepatitis. Liver can rarely become involved in
granulomatosis with polyangiitis where it can cause chronic
granulomatous inflammation [25–27]. It has been described
in autopsy reports of patients with GPA. In the literature
search of PubMed database, there is a report describing
granulomatous and vasculitic lesions in the liver and spleen
[28] in the autopsy whereas the nasal biopsy was negative.
The authors emphasized that the biopsy may be negative from
typical sites in atypical disease forms. In yet another report
[29], vasculitic hepatic lesion caused aneurysmal rupture
of hepatic artery. I believe that our patient presented with
an atypical, extremely rare presentation with cutaneous and
hepatic involvement which remains unexplained with other
disease processes. Although cutaneous polyarteritis nodosa
can present with nodules and leg ulcers, there is absence of
visceral involvement, integrity of muscular arteries in the
deep dermal tissue is compromised, and granulomatous
inflammation is not a feature [30].
The aim of treatment is to prevent the morbidity and
mortality associated with the disease and is usually done by
remission induction and remission maintenance [4]. Oral
cyclophosphamide (CYC) in combination with high-dose
glucocorticoids has long been the criterion standard. Due
to the toxicities associated with cyclophosphamide (CYC),
notably sterility and bladder cancer, Rituximab combined
with high-dose glucocorticoids represents an alternative for
induction of remission. It is a chimeric monoclonal antiCD20 IgG1 antibody that induces apoptosis of B cells.
For localized disease, methotrexate can be substituted for
CYC and added to high-dose steroids, for example, prednisone 1 mg/kg/day for induction of remission. Azathioprine,
leflunomide, and methotrexate are all agents for maintenance
of remission which should be continued for at least 18
months. We recommended Rituximab to our patient for
remission induction as she had refused CYC. While she
awaited medical insurance cover for the former, treatment
was commenced with prednisone 1 mg/kg/day and azathioprine at a dose of 2 mg/kg/day with remarkable resolution of
the lesions after 7 weeks of therapy (Figure 8).
Untreated granulomatosis with polyangiitis is uniformly
fatal with mortality of up to 90% at 2 years [4]. Although
remission is generally maintained, relapses are common and
mortality remains high. A study on long term outcome of
GPA patients reported a survival time of 8.5 years [31]. It is
therefore important to identify this disease even with limited
presentation so that appropriate treatment can be initiated
and tailored for an individual patient. Mimics of cutaneous
granulomatous vasculitis should be thoroughly investigated
and excluded. Where ANCA is negative, tissue biopsy should
be obtained to arrive at the diagnosis.
Although numerous classification criteria have been
developed to aid in prompt diagnosis and management, there
are always instances whereby these diseases can present in an
atypical way. The case report that we have highlighted will
prompt clinicians to consider the limited and localized forms
of granulomatosis with polyangiitis (GPA) so that the disease
is recognized early and treated effectively.
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[30] A. Bauzá, A. España, and M. Idoate, “Cutaneous polyarteritis
nodosa,” British Journal of Dermatology, vol. 146, no. 4, pp. 694–
699, 2002.
[31] G. Anderson, E. T. Coles, M. Crane et al., “Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985.
A report by a sub-committee of the British Thoracic Society
Research Committee,” Quarterly Journal of Medicine, vol. 83, no.
302, pp. 427–438, 1992.

Case Reports in Rheumatology
[32] V. Brazzelli, C. Vassallo, F. Baldini, A. Ravelli, A. Martini, and
G. Borroni, “Wegener granulomatosis in a child: cutaneous
findings as the presenting signs,” Pediatric Dermatology, vol. 16,
no. 4, pp. 277–280, 1999.
[33] V. Sinovich and J. Snow, “Protracted superficial Wegener’s
granulomatosis,” Australasian Journal of Dermatology, vol. 44,
no. 3, pp. 207–214, 2003.
[34] T. Kawakami, W. Obara, Y. Soma, and M. Mizoguchi, “Palisading neutrophilic granulomatous dermatitis in a Japanese patient
with Wegener’s granulomatosis,” Journal of Dermatology, vol. 32,
no. 6, pp. 487–492, 2005.
[35] I. Ben Ghorbel, A. S. Dhrif, M. Miled, and M. H. Houman,
“Cutaneous manifestations as the initial presentation of
Wegener’s granulomatosis,” La Presse Médicale, vol. 36, no. 4,
part 1, pp. 619–622, 2007.

7

MEDIATORS
of

INFLAMMATION

The Scientific
World Journal
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Gastroenterology
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Hindawi Publishing Corporation
http://www.hindawi.com

Diabetes Research
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

International Journal of

Journal of

Endocrinology

Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com

Disease Markers

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Submit your manuscripts at
http://www.hindawi.com
BioMed
Research International

PPAR Research
Hindawi Publishing Corporation
http://www.hindawi.com

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Journal of

Obesity

Journal of

Ophthalmology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Evidence-Based
Complementary and
Alternative Medicine

Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Oncology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Parkinson’s
Disease

Computational and
Mathematical Methods
in Medicine
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

AIDS

Behavioural
Neurology
Hindawi Publishing Corporation
http://www.hindawi.com

Research and Treatment
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Oxidative Medicine and
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

